Accendra Health (ACH) Receivables (2009 - 2026)

Accendra Health (ACH) has 18 years of Receivables data on file, last reported at $103.7 million in Q1 2026.

• Receivables for Q1 2026 came in at $103.7 million, down 82.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.7 million (down 82.13% YoY), and the FY2025 annual result was $95.9 million, down 56.06% from the prior year.
• Receivables grew to $103.7 million in Q1 2026 per ACH's latest filing, from $95.9 million in the prior quarter.
• Over five years, Receivables peaked at $775.8 million in Q1 2022 and troughed at $95.9 million in Q4 2025.
• A 5-year average of $537.5 million and a median of $662.4 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2026: Receivables advanced 12.02% in 2022, then plunged 82.13% in 2026.
• A 5-year view of Receivables shows it stood at $763.5 million in 2022, then slipped by 21.64% to $598.3 million in 2023, then tumbled by 63.52% to $218.3 million in 2024, then tumbled by 56.06% to $95.9 million in 2025, then rose by 8.13% to $103.7 million in 2026.
• Business Quant data shows ACH's Receivables at $103.7 million in Q1 2026, $95.9 million in Q4 2025, and $202.7 million in Q3 2025.